Anzeigenschluss: 12.06.2025
Erscheinungstermin: 27.06.2025
Top-Thema
Wirtschaft & Gesundheit
Schwerpunkt: "ASCO 2025 Spezial"
Highlights vom ASCO Annual Meeting of the American Society of Clinical Oncology in Chicago IL/USA vom 30.05. - 03.06.2025
Medizin
AML
Niederwieser D et al.
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study
DLBCL
Bartlett NL et al.
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Ösophaguskarzinom
Van der Wilk BJ et al.
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial
CRC
Stintzing S et al.
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study
CRC
André T et al.
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
NSCLC
Felip E et al.
Subcutaneous Versus Intravenous Pembrolizumab, in Combination With Chemotherapy, for Treatment of Metastatic Non-Small Cell Lung Cancer: The Phase 3 3475A-D77 Trial
NSCLC
Pérol M et al.
Taletrectinib in ROS1+ Non-Small Cell Lung Cancer: TRUST
Brustkrebs
Hernström V et al.
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study
Brustkrebs
Lambertini M et al.
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status
RCC
Powles T et al.
Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial
Blasenkrebs
Scilipoti P et al.
Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancer
Allgemeine Onkologie: HPV-assoziierte Tumoren
Floudas CS et al.
Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial
Allgemeine Onkologie
Jannot AS et al.
High Risk of Digestive Cancers in Patients With Celiac Disease: A Nationwide Case-Control Cohort Study
Kongressbericht: AGSMO-Jahreskongress 2025
Neues vom Jahreskongress der AGSMO (Arbeitsgemeinschaft Supportive Maßnahmen in der Onkologie der Deutschen Krebsgesellschaft e. V.) in Berlin am 24.05.2025
Kongressbericht: CIMT 2025
Aktuelles vom 22nd Annual Cancer Immunotherapy (CIMT) Meeting 2025 in Mainz vom 12.05. - 14.05.2025
*Die Redaktion behält sich aktuelle Änderungen vor.